
What was Mark Cuban doing “gate-crashing” Shelly Palmer’s Innovation Breakfast?
My worlds of content and health care collided in a serendipitous way this morning when, at the conclusion of my annual beloved experience attending and learning at the Shelly Palmer Innovation Series breakfast which focuses on content, media, entertainment, and now AI mashing up everywhere, all at once, Mark Cuban appeared as a late-breaking guest in fireside chat with Shelly. Here’s my photo to prove it, circa 903 am this morning. 
Before even chatting about AI, X, and his very purposeful investment in BlueSky, Mark took the time to explain how generic Sildenafil can now be priced (at Mark Cuban Cost Plus Drugs portal) like, in his own words, “a big bag of M&M’s.”
He urged everyone in the over-packed SRO room of marketers, brand managers, media producers and industry analysts to “go price shopping for health care.” 
That’s the mission of his venture, Mark Cuban Cost Plus Drugs. Mark is challenging the PBM model that people who are insured on prescription drug plans are subject to dealing with….and now, he says, the plans are for his company to address health care beyond the Rx.
And that can’t come too soon, Mr. Cuban!
As a veteran attendee for 16 years of the CES conference, I have seen health/care, everywhere, for at least a decade via digital health exhibitors, content, and through networking with other health-focused attendees.
Now, in this convergence of Cuban + Palmer this morning, I know for sure: health/care is everywhere, all at once, at #CES2025.
Thank you, Shelly, for this amazing last-minute add to your always-insightful meet-up. I’m so grateful.





Thank you
Jane joined host Dr. Geeta "Dr. G" Nayyar and colleagues to brainstorm the value of vaccines for public and individual health in this challenging environment for health literacy, health politics, and health citizen grievance.
I'm grateful to be part of the Duke Corporate Education faculty, sharing perspectives on the future of health care with health and life science companies. Once again, I'll be brainstorming the future of health care with a cohort of executives working in a global pharmaceutical company.